BLOG

CAR T cell therapies are generally optimized for short-term cellular

Researchers have bolstered the power of chimeric antigen receptor (CAR)-T

Researchers have created a laboratory-developed, three-dimensional organoid model derived from

Hereditary angioedema, a C1 inhibitor deficiency that is caused by

Kidney cancer is one of the most common types of

Researchers have used CRISPR/Cas9 technology to engineer donor T cells

CAR T cells currently in clinical use are designed to